Reversing Drug Induced Coagulopathy in the ICU
To begin the course, please login or register by clicking ENROLL. After logging in, you will be able to complete the pretest and view the video/documents. You will have the option to complete the posttest, evaluation and receive credit. Some courses may have an associated cost.
Starts On:
7/1/2019: 12:00 AM
Ends On:
6/30/2020: 12:00 AM
Session Type:
Internet Activity Enduring Material
Credits:
0.5
Description:
Clinical Pharmacy Specialist
Medical Intensive Care Unit
Barnes-Jewish Hospital
Disclosures
Financial Relationships: Speaker has nothing to disclose.
Presenters should indicate if speaking off label. This activity originated as a presentation at the CME activity, 19th Annual St. Louis Critical Care Update, September 15, 2018, which was supported in part by The Foundation for Barnes-Jewish Hospital and CSL Behring LLC.
Professor of Medicine
Division of Pulmonary and Critical Care Medicine
Washington University School of Medicine in St. Louis
Director, Medical Critical Care, Barnes-Jewish Hospital
Financial Relationships:
Speaker's Bureau/Honoraria: Allergan, Inc., Actavis, The Medicines Company,
Consulting/Advisory Committees: Merck & Company, Inc., Accelerate, Allergan, Inc., Arsanis, Paratek Pharmaceuticals, Inc, Paraxel
Paul Juang, PharmD, BCPS
Financial Relationships:
Speaker's Bureau/Honoraria: La Jolla Pharmaceuticals
Donna Prentice, RN, AMSN(R), ACNS-BC
Clinical Nurse Specialist
Barnes Jewish Hospital, St Louis, MO
Financial Relationships: Speaker has nothing to disclose.
Peggy Reed-Watts, MS, RRT
Manager, Respiratory Care Services
Barnes Jewish Hospital, St Louis, MO
Financial Relationships: Speaker has nothing to disclose.
Faculty
Katherine Roberts, PharmD, BCCCPClinical Pharmacy Specialist
Medical Intensive Care Unit
Barnes-Jewish Hospital
Disclosures
Financial Relationships: Speaker has nothing to disclose.
Presenters should indicate if speaking off label. This activity originated as a presentation at the CME activity, 19th Annual St. Louis Critical Care Update, September 15, 2018, which was supported in part by The Foundation for Barnes-Jewish Hospital and CSL Behring LLC.
Planning Committee
Marin H. Kollef, MDProfessor of Medicine
Division of Pulmonary and Critical Care Medicine
Washington University School of Medicine in St. Louis
Director, Medical Critical Care, Barnes-Jewish Hospital
Financial Relationships:
Speaker's Bureau/Honoraria: Allergan, Inc., Actavis, The Medicines Company,
Consulting/Advisory Committees: Merck & Company, Inc., Accelerate, Allergan, Inc., Arsanis, Paratek Pharmaceuticals, Inc, Paraxel
Paul Juang, PharmD, BCPS
Financial Relationships:
Speaker's Bureau/Honoraria: La Jolla Pharmaceuticals
Donna Prentice, RN, AMSN(R), ACNS-BC
Clinical Nurse Specialist
Barnes Jewish Hospital, St Louis, MO
Financial Relationships: Speaker has nothing to disclose.
Peggy Reed-Watts, MS, RRT
Manager, Respiratory Care Services
Barnes Jewish Hospital, St Louis, MO
Financial Relationships: Speaker has nothing to disclose.
Objectives:
The intended result of this activity is increased knowledge/competence, and upon completion of this course, participants should be able to:
- Describe the pharmacology of commonly prescribed anticoagulants and available reversal agents
- Identify and select appropriate reversal strategies for bleeding associated with oral anticoagulant therapies
Additional Information:
Target Audience
This course is designed by and for critical care specialists, pulmonologists, general surgeons, anesthesiologists, hospitalists, internists, family practice and emergency medicine physicians, as well as, pharmacists, physician assistants, nurse practitioners, and nurses in these fields.
Publication Date: July 1, 2019
Expiration Date: June 30, 2020
Target Audience
This course is designed by and for critical care specialists, pulmonologists, general surgeons, anesthesiologists, hospitalists, internists, family practice and emergency medicine physicians, as well as, pharmacists, physician assistants, nurse practitioners, and nurses in these fields.
Publication Date: July 1, 2019
Expiration Date: June 30, 2020
Accreditation Information:
In support of improving patient care, Washington University School of Medicine in St. Louis is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Awarded for this Activity:
In support of improving patient care, Washington University School of Medicine in St. Louis is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Awarded for this Activity:
Credit Statement:
American Medical Association (AMA Credit)
Washington University School of Medicine in St. Louis designates this enduring material for a maximum of .5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Medical Association (AMA Credit)
Washington University School of Medicine in St. Louis designates this enduring material for a maximum of .5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
References:
- J Blood Med 2017: 8 141-149.
- Clin Appl Thromb Hemost 2017. 23(5):410-415.
- Neurocrit Care (2016) 24:6-46.
- Am J Health Syst Pharm 2016; 73(supp 2):S14-16.
- Emerg Med Clin N Am 36 (2018) 585-601.
Disclosure Information:
It is the policy of Washington University School of Medicine in St. Louis, Continuing Medical Education, to ensure balance, independence, objectivity and scientific rigor in all its educational activities. All planners, faculty and other persons who may influence content of this CME activity have disclosed all relevant financial relationships with commercial interests. All disclosures have been reported and are indicated with their presentations. Any potential conflicts were addressed and resolved.
Presenters are also expected to openly disclose inclusion of discussion of any off-label, experimental, or investigational use of drugs or devices in their presentations.
Presentations are expected to be based on evidence that is accepted within the profession of medicine as adequate justification for their indication in the care of patients. All scientific research should conform to the generally accepted standards of experimental design, data collection and analysis. These presentations are not an endorsement of any commercial interests.
These presentations are the views and experiences of the presenters. The presenters' views do not represent the policy or position of Washington University School of Medicine in St. Louis. Washington University School of Medicine in St. Louis, Continuing Medical Education, is the provider for CME credits.
Presenters are also expected to openly disclose inclusion of discussion of any off-label, experimental, or investigational use of drugs or devices in their presentations.
Presentations are expected to be based on evidence that is accepted within the profession of medicine as adequate justification for their indication in the care of patients. All scientific research should conform to the generally accepted standards of experimental design, data collection and analysis. These presentations are not an endorsement of any commercial interests.
These presentations are the views and experiences of the presenters. The presenters' views do not represent the policy or position of Washington University School of Medicine in St. Louis. Washington University School of Medicine in St. Louis, Continuing Medical Education, is the provider for CME credits.
